Klaria's objective is to combine the Company's patented drug delivery platform with the most relevant and effective substances when it comes to pain relief in the event of migraine and cancer-related breakthrough pain. 

Objective in 2017-2018 is to complete the formulations in all projects and to start testing priority projects in clinical trials.